ARCHIVES

BRAF Mutation Testing Classifies Indeterminate FNA Samples

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Mendelsohn To Step Down As MD Anderson President

December 10, 2010

AACR’s Elion Award Invites Applicants

December 10, 1993

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997